Published in Acad Med on April 01, 2008
Aligning the goals of community-engaged research: why and how academic health centers can successfully engage with communities to improve health. Acad Med (2012) 2.32
Eight years of building community partnerships and trust: the UCLA family medicine community-based participatory research experience. Acad Med (2009) 1.87
Linking practice-based research networks and Clinical and Translational Science Awards: new opportunities for community engagement by academic health centers. Acad Med (2010) 1.50
Reducing health disparities through a culturally centered mentorship program for minority faculty: the Southwest Addictions Research Group (SARG) experience. Acad Med (2009) 1.21
The role of the clinical and translational science awards program in improving the quality and efficiency of clinical research. Chest (2011) 1.08
Population health and the academic medical center: the time is right. Acad Med (2014) 0.92
Engaging the Community in the Dissemination, Implementation, and Improvement of Health-Related Research. Clin Transl Sci (2015) 0.89
Understanding the supports of and challenges to community engagement in the CTSAs. Clin Transl Sci (2014) 0.87
Evaluating community engagement in an academic medical center. Acad Med (2014) 0.85
Teaching population health: a competency map approach to education. Acad Med (2013) 0.83
Perceptions community residents have about partner institutions and clinical research. Clin Transl Sci (2013) 0.76
Implementing Community Engagement as a Mission at the David Geffen School of Medicine at the University of California, Los Angeles. J Health Care Poor Underserved (2016) 0.75
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet (2005) 4.29
Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science (2002) 4.18
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44
Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem (2005) 3.06
The role of academic health science systems in the transformation of medicine. Lancet (2009) 2.98
STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat Cell Biol (2008) 2.89
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther (2006) 2.85
Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J (2007) 2.30
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation (2003) 2.27
Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem (2002) 2.17
The case for practical clinical trials in psychiatry. Am J Psychiatry (2005) 2.02
Transcriptional regulation of cardiac progenitor cell populations. Circ Res (2004) 2.01
An initiative in mentoring to promote residents' and faculty members' careers. Acad Med (2004) 1.95
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol (2010) 1.95
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension (2006) 1.91
Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation (2005) 1.87
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med (2003) 1.81
The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med (2003) 1.80
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol (2003) 1.75
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell (2007) 1.72
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation (2002) 1.67
Creating a new structure for research on health care effectiveness. J Investig Med (2005) 1.64
Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem (2002) 1.62
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res (2010) 1.60
Molecular genetics and genomics of heart failure. Nat Rev Genet (2004) 1.60
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation (2006) 1.59
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics (2002) 1.57
Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. J Biol Chem (2002) 1.57
Cell cycle-dependent regulation of smooth muscle cell activation. Arterioscler Thromb Vasc Biol (2004) 1.51
Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.51
Prospective medicine: the next health care transformation. Acad Med (2003) 1.51
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells (2009) 1.50
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol (2008) 1.49
Just for Us: an academic medical center-community partnership to maintain the health of a frail low-income senior population. Gerontologist (2006) 1.47
Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res (2006) 1.46
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation (2004) 1.46
Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice. Am J Physiol Cell Physiol (2004) 1.43
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation (2004) 1.41
Making translation work. Science (2011) 1.40
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ Res (2004) 1.39
Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol (2002) 1.38
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol (2008) 1.35
TRPC3 channels confer cellular memory of recent neuromuscular activity. Proc Natl Acad Sci U S A (2004) 1.32
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation (2004) 1.22
Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther (2010) 1.19
Perspective: global medicine: opportunities and challenges for academic health science systems. Acad Med (2011) 1.17
Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol (2007) 1.15
Training the next generation of physician-executives: an innovative residency pathway in management and leadership. Acad Med (2011) 1.14
Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest (2005) 1.13
Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity. Mol Cell Biol (2008) 1.12
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells (2007) 1.09
Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J (2006) 1.09
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci U S A (2004) 1.09
Sensible guidelines for the conduct of large randomized trials. Clin Trials (2008) 1.07
Personalized health planning. Science (2003) 1.07
Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics (2003) 1.06
Homer modulates NFAT-dependent signaling during muscle differentiation. Dev Biol (2005) 1.06
" I take the good with the bad, and I moisturize": defying middle age in the new millennium. Menopause (2007) 1.06
Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression. Mol Cell Endocrinol (2004) 1.06
Liability issues for data monitoring committee members. Clin Trials (2004) 1.05
Conditional expression of SV40 T-antigen in mouse cardiomyocytes facilitates an inducible switch from proliferation to differentiation. J Biol Chem (2003) 1.04
The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell (2003) 1.04
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol (2006) 1.02
Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development. Biochem Biophys Res Commun (2002) 1.01
Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling. Biochem Biophys Res Commun (2005) 1.01
The Child and Adolescent Psychiatry Trials Network (CAPTN). J Am Acad Child Adolesc Psychiatry (2004) 1.00
Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Practice profile. Community collaboration to improve care and reduce health disparities. Health Aff (Millwood) (2010) 0.99
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation (2002) 0.98
Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol Genomics (2006) 0.98
Resident stem cells are not required for exercise-induced fiber-type switching and angiogenesis but are necessary for activity-dependent muscle growth. Am J Physiol Cell Physiol (2006) 0.97
Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation. J Biol Chem (2005) 0.96
Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am J Physiol Heart Circ Physiol (2007) 0.95
Risk factor criteria. Circulation (2004) 0.95
Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study. Hypertens Res (2002) 0.95
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation (2005) 0.94
Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation (2003) 0.94
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. Int J Cardiol (2004) 0.93
Adult renal mesenchymal stem cell-like cells contribute to juxtaglomerular cell recruitment. J Am Soc Nephrol (2013) 0.93
Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha to coactivate nuclear receptors estrogen-related receptor alpha and PPARalpha. Mol Cell Biol (2009) 0.93
Protein-coated poly(L-lactic acid) fibers provide a substrate for differentiation of human skeletal muscle cells. J Biomed Mater Res A (2004) 0.93
Transcription factor decoy. Circ Res (2002) 0.92
Genetic markers: progress and potential for cardiovascular disease. Circulation (2004) 0.91
Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology. Stem Cells (2013) 0.91
A global partnership in medical education between Duke University and the National University of Singapore. Acad Med (2008) 0.91
Depressive symptoms, physical activity, and weight gain in premenopausal Latina and White women. Maturitas (2006) 0.90
Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J Am Coll Cardiol (2006) 0.90
Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol (2004) 0.90
Identification of a novel set of genes regulated by a unique liver X receptor-alpha -mediated transcription mechanism. J Biol Chem (2003) 0.89
beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing. Am Heart J (2010) 0.89
Incubating the research independence of a medical scientist training program graduate: a case study. Acad Med (2015) 0.88
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation (2004) 0.88